Inventor · disambiguated record
Jeanne Baker
Also filed as: BAKER JEANNE · BAKER JEANNE BRANIFF · BAKER JEANNE E
14 granted patents·5 pending applications·74 citations·filing 2001–2023
91Inventor score
Files withSCHERER TECHNOLOGIES LLC R P6PROTHENA BIOSCIENCES LTD5TEIJIN PHARMA LTD3FLANAGAN KENNETH1MERCK SHARP & DOHME LLC1
Top patents by PatentIndex Score
19 records- 0195US9447190B2Anti-MCAM antibodies and associated methods of useNEOTOPE BIOSCIENCES LTD·Filed 2013·Granted Sep 20, 2016·32 cites·22 claims
- 0294US10414825B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 17, 2019·14 cites·25 claims
- 0391US10894829B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Jan 19, 2021·3 cites·17 claims
- 0491US10556950B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2018·Granted Feb 11, 2020·9 cites·36 claims
- 0590US10584177B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2017·Granted Mar 10, 2020·6 cites·8 claims
- 0689US10407507B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 10, 2019·6 cites·9 claims
- 0788US11739143B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Aug 29, 2023·2 cites·16 claims
- 0884US12018308B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 0983US11702467B2High affinity antibodies targeting tau phosphorylated at serine 413MERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 18, 2023·1 cites·33 claims
- 1077US11655492B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted May 23, 2023·0 cites·10 claims
- 1174US9951367B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2015·Granted Apr 24, 2018·1 cites·16 claims
- 1273US11053529B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 6, 2021·0 cites·25 claims
- 1372US10683527B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted Jun 16, 2020·0 cites·37 claims
- 1470US2020216560A1Anti-MCAM Antibodies And Associated Methods Of UsePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 1565US10344311B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Jul 9, 2019·0 cites·24 claims
- 1664US2005033677A1Electronic flex card adjudication system and methodSMARTFLEX LLC·Filed 2004·Application pending·0 cites
- 1757US2003061153A1Electronic flex card adjudication system and methodFiled 2001·Application pending·0 cites
- 1854US2020165336A1Mcam antagonists and methods of treatmentPROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 1947US2014314744A1Mcam antagonists and methods of treatmentFLANAGAN KENNETH·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →